Sequential Deceleration Hides Behind the AI Growth Story

The headline 13.9% YoY revenue growth looks solid. But step into the quarter and the story flips: ₹72,275 Cr revenue grew just 2.2% sequentially—the slowest rate of the four consecutive quarters management cited. More troubling, net profit actually contracted 2.6% QoQ despite essentially flat revenue. This is not momentum; it is deceleration masked by a strong base comparison.

Management reported a net margin of 19.2% on the call. The delivered result shows 18.2% (₹13,420 Cr net profit / ₹72,275 Cr revenue). That 100 basis point gap is attributed to a cost category reclassification, but the reconciliation was never explicit. For a franchise of TCS's size and scrutiny, this ambiguity is unnecessary and erodes credibility. The issue is not the reclassification itself—it is that the market and analysts heard 19.2% when the true delivered number is 18.2%.

Wage inflation is now quantified and structural. Management explicitly disclosed that 170 basis points of margin compression came from rolling out annual salary increments for the global workforce. Currency provided only 40 bps of offset. This is not a one-quarter phenomenon; it reflects structural labor cost inflation that will persist as long as hiring and upskilling continue. The path to management's 25%+ operating margin target has just extended.

Vertical weakness is explicit. Prior guidance spoke of 'broad-based growth'; Q1 reveals material softness in Consumer (airlines, non-essential retail impacted by geopolitical uncertainty), Life Sciences (declined this quarter), and Manufacturing (auto segment weakness due to tariff pressure and EV recalibration). Management now expects recovery in Q2, but no proof points—only 'pent-up backlog' language and conversation evidence ('Life Sciences uptick' noted but unquantified).

AI mega deal cadence validated but revenue remains non-recurring. Six mega deals in five quarters (including ₹800M SKF transformation, ServiceNow partnership, ABB collaboration) is real. Q1 delivered $9.5B in total contract value. However, AI revenue itself is acknowledged as lumpy: 1–2 quarter projects by nature. Q1 added $75M in incremental AI revenue; the prior quarter added $125M. This volatility contradicts the 'annuity' narrative; the $2.6B annualized figure masks project lumpiness.

The post-result pop held. TCS announced results with the stock closing at ₹2,049.5 pre-result. Day 1 saw a +0.95% move; by day 3 it was +7.37%; by day 5 it held at +7.39%. The rally did not fade—a signal that the market found some relief in the result, perhaps due to the AI mega deal narrative and confirmation that wage/macro headwinds are known rather than hidden. However, the market's own verdict is cautious: it popped on relief, not conviction.

But FII ownership is trimming. FII stake in TCS has declined from 12.04% (FY25 Q4, a year ago) to 9.66% (FY26 Q4, the most recent filed quarter)—a 238 basis point decline. The latest QoQ change (FY26 Q4 vs. FY26 Q3) shows another -71 basis point drop. Domestic institutional investors (DII) are adding (+54 bps QoQ), but foreign institutions are clearly rotating out. This divergence is a warning: international portfolio managers are losing patience with sequential deceleration and margin uncertainty.

Valuation context: down 29% from all-time highs, but not yet a screaming buy. TCS trades at ₹2,365.6, down 29.39% from its all-time high of ₹3,350. It sits above its 20-day (₹2,224.31) and 50-day (₹2,200.29) simple moving averages but well below the 200-day average (₹2,688.27), suggesting an intermediate recovery within a longer-term downtrend. RSI of 68.8 (neutral, not overbought) and normal volume suggest the recovery is orderly, not panic-driven. The 52-week range is ₹1,976.8–₹3,350; at ₹2,365.6, the stock is off the lows (+19.67%) but not a bargain.

Bulk deal watch: The last recorded block deal (June 24) was a mutual transfer between two tranches of the Government Pension Investment Fund managed by MTBJ (₹1,83,328 shares @ ₹2,059.60, both buy and sell). No promoter or insider-linked selling near the highs; this is routine fund rebalancing, not a red flag.